You are about to leave the Clinical Value website now.

Cancel

Cancer Type: Liver

Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma

Posted on by Isabel Low
3155

…

Turning the Tide Against Hep B and HCC: Insights from New Zealand’s National Screening and Surveillance Program

Posted on by Isabel Low
NZ LEAP banner

…

ESMO Asia 2023 Symposium – HCC illuminated: Exploring future frontiers with systemic immunotherapies

ESMO Asia 2023 presentation slide chong toh HCC illuminated 1

Missed the satellite symposium session from ESMO Asia 2023? Access the webcast recording here….

Development and Clinical Validation of a Novel Algorithmic Score (GAAD) for the Detection of Early-stage Hepatocellular Carcinoma

Posted on by Isabel Low
EASL ILC 2023 poster piratvisuth development clinical validation and implementation of a novel page 0001

This study aims to establish and train the algorithm coefficients, and clinically validate the performance of the GAAD algorithm in differentiating HCC and benign chronic liver disease (CLD), across different regions and aetiologies….

Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis

Posted on by Isabel Low
China

…

The Pursuit for Better Patient Outcomes – Innovating HCC Management at Siriraj Hospital

Posted on by Isabel Low
Siriraj Hospital

…

The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.

OK